|
1
|
Rodriguez-Morales AJ, Cardona-Ospina JA,
Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y,
Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK,
Franco-Paredes C, Henao-Martinez AF, et al: Clinical, laboratory
and imaging features of COVID-19: A systematic review and
meta-analysis. Travel Med Infect Dis. 34(101623)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zaim S, Chong JH, Sankaranarayanan V and
Harky A: COVID-19 and multiorgan response. Curr Probl Cardiol.
45(100618)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Georgakopoulou VE, Avramopoulos P,
Papalexis P, Bitsani A, Damaskos C, Garmpi A, Venetikou MS,
Paramythiotis D, Karlafti E, Sklapani P, et al: COVID-19 induced
hypoparathyroidism: A case report. Exp Ther Med.
23(346)2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Georgakopoulou VE, Gkoufa A, Damaskos C,
Papalexis P, Pierrakou A, Makrodimitri S, Sypsa G, Apostolou A,
Asimakopoulou S, Chlapoutakis S, et al: COVID-19-associated acute
appendicitis in adults. A report of five cases and a review of the
literature. Exp Ther Med. 24(482)2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Gabarre P, Dumas G, Dupont T, Darmon M,
Azoulay E and Zafrani L: Acute kidney injury in critically ill
patients with COVID-19. Intensive Care Med. 46:1339–1348.
2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Cholongitas E, Bali T, Georgakopoulou VE,
Giannakodimos A, Gyftopoulos A, Georgilaki V, Gerogiannis D,
Basoulis D, Eliadi I, Karamanakos G, et al: Prevalence of abnormal
liver biochemistry and its impact on COVID-19 patients' outcomes: A
single-center Greek study. Ann Gastroenterol. 35:290–296.
2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Martínez-García L, Espinel MA, Abreu M,
González-Alba JM, Gijón D, McGee A, Cantón R, Galán JC and Aranaz
J: Emergence and spread of B.1.1.7 lineage in primary care and
clinical impact in the morbi-mortality among hospitalized patients
in Madrid, Spain. Microorganisms. 9(1517)2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
El-Shabasy RM, Nayel MA, Taher MM,
Abdelmonem R, Shoueir KR and Kenawy ER: Three waves changes, new
variant strains, and vaccination effect against COVID-19 pandemic.
Int J Biol Macromol. 204:161–168. 2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Darif D, Hammi I, Kihel A, El Idrissi Saik
I, Guessous F and Akarid K: The pro-inflammatory cytokines in
COVID-19 pathogenesis: What goes wrong? Microb Pathog.
153(104799)2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Regolo M, Vaccaro M, Sorce A, Stancanelli
B, Colaci M, Natoli G, Russo M, Alessandria I, Motta M, Santangelo
N, et al: Neutrophil-to-lymphocyte ratio (NLR) is a promising
predictor of mortality and admission to intensive care unit of
COVID-19 patients. J Clin Med. 11(2235)2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sayah W, Berkane I, Guermache I, Sabri M,
Lakhal FZ, Yasmine Rahali S, Djidjeli A, Lamara Mahammed L, Merah
F, Belaid B, et al: Interleukin-6, procalcitonin and
neutrophil-to-lymphocyte ratio: Potential immune-inflammatory
parameters to identify severe and fatal forms of COVID-19.
Cytokine. 141(155428)2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Georgakopoulou VE, Vlachogiannis NI,
Basoulis D, Eliadi I, Georgiopoulos G, Karamanakos G, Makrodimitri
S, Samara S, Triantafyllou M, Voutsinas PM, et al: A simple
prognostic score for critical COVID-19 Derived from patients
without comorbidities performs well in unselected patients. J Clin
Med. 11(1810)2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Georgakopoulou VE, Makrodimitri S,
Triantafyllou M, Samara S, Voutsinas PM, Anastasopoulou A,
Papageorgiou CV, Spandidos DA, Gkoufa A, Papalexis P, et al:
Immature granulocytes: Innovative biomarker for SARS-CoV-2
infection. Mol Med Rep. 26(217)2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Georgakopoulou VE, Garmpis N, Damaskos C,
Valsami S, Dimitroulis D, Diamantis E, Farmaki P, Papageorgiou CV,
Makrodimitri S, Gravvanis N, et al: The impact of peripheral
eosinophil counts and eosinophil to lymphocyte ratio (ELR) in the
clinical course of COVID-19 patients: A retrospective study. In
Vivo. 35:641–648. 2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wang R, He M, Yin W, Liao X, Wang B, Jin
X, Ma Y, Yue J, Bai L, Liu D, et al: The Prognostic nutritional
index is associated with mortality of COVID-19 patients in Wuhan,
China. J Clin Lab Anal. 34(e23566)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Onodera T, Goseki N and Kosaki G:
Prognostic nutritional index in gastrointestinal surgery of
malnourished cancer patients. Nihon Geka Gakkai Zasshi.
85:1001–1005. 1984.PubMed/NCBI(In Japanese).
|
|
17
|
Kang SH, Cho KH, Park JW, Yoon KW and Do
JY: . Onodera's prognostic nutritional index as a risk factor for
mortality in peritoneal dialysis patients. J Korean Med Sci.
27:1354–1358. 2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Moon SW, Lee EH, Choi JS, Leem AY, Lee SH,
Lee SH, Kim SY, Chung KS, Jung JY, Park MS, et al: Impact of
prognostic nutritional index on outcomes in patients with
Mycobacterium avium complex pulmonary disease. PLoS One.
15(e0232714)2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
National Institutes of Health (NIH):
Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. NIH,
Bethesda, MD, 2021. https://www.covid19treatmentguidelines.nih.gov/.
Accessed October 20, 2021.
|
|
20
|
Zhang J, Wang X, Jia X, Li J, Hu K, Chen
G, Wei J, Gong Z, Zhou C, Yu H, et al: Risk factors for disease
severity, unimprovement, and mortality in COVID-19 patients in
Wuhan, China. Clin Microbiol Infect. 26:767–772. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Gong J, Ou J, Qiu X, Jie Y, Chen Y, Yuan
L, Cao J, Tan M, Xu W, Zheng F, et al: A tool for early prediction
of severe coronavirus disease 2019 (COVID-19): A multicenter study
using the risk nomogram in Wuhan and Guangdong, China. Clin Infect
Dis. 71:833–840. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Peters SJ, Vanhaecke T, Papeleu P, Rogiers
V, Haagsman HP and van Norren K: Co-culture of primary rat
hepatocytes with rat liver epithelial cells enhances
interleukin-6-induced acute-phase protein response. Cell Tissue
Res. 340:451–457. 2010.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Qi
Y, Sun R, Tian Z, Xu X and Wei H: Pathogenic T-cells and
inflammatory monocytes incite inflammatory storms in severe
COVID-19 patients. Natl Sci Rev. 7:998–1002. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y,
Shi J, Zhou M, Wu B, Yang Z, et al: Risk factors for severity and
mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin
Immunol. 146:110–118. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yang Y, Shen C, Li J, Yuan J, Wei J, Huang
F, Wang F, Li G, Li Y, Xing L, et al: Plasma IP-10 and MCP-3 levels
are highly associated with disease severity and predict the
progression of COVID-19. J Allergy Clin Immunol. 146:119–127.e4.
2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tan L, Wang Q, Zhang D, Ding J, Huang Q,
Tang YQ, Wang Q and Miao H: Lymphopenia predicts disease severity
of COVID-19: A descriptive and predictive study. Signal Transduct
Target Ther. 5(33)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S,
Huang H, Zhang L, Zhou X, Du C, et al: Risk factors associated with
acute respiratory distress syndrome and death in patients with
coronavirus disease 2019 Pneumonia in Wuhan, China. JAMA Intern
Med. 180:934–943. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Han Y, Zhang H, Mu S, Wei W, Jin C, Xue Y,
Tong C, Zha Y, Song Z and Gu G: Lactate dehydrogenase, a risk
factor of severe COVID-19 patients. medRxiv: doi: https://doi.org/10.1101/2020.03.24.20040162.
|
|
29
|
Xu Z, Shi L, Wang Y, Zhang J, Huang L,
Zhang C, Liu S, Zhao P, Liu H, Zhu L, et al: Pathological findings
of COVID-19 associated with acute respiratory distress syndrome.
Lancet Respir Med. 8:420–422. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhao J, Zhao J, Van Rooijen N and Perlman
S: Evasion by stealth: Inefficient immune activation underlies poor
T cell response and severe disease in SARS-CoV-infected mice. PLoS
Pathog. 5(e1000636)2009.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Channappanavar R and Perlman S: Pathogenic
human coronavirus infections: Causes and consequences of cytokine
storm and immunopathology. Semin Immunopathol. 39:529–539.
2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Georgakopoulou VE, Lembessis P, Skarlis C,
Gkoufa A, Sipsas NV and Mavragani CP: Hematological abnormalities
in COVID-19 disease: Association with type I interferon pathway
activation and disease outcomes. Front Med (Lausanne).
9(850472)2022.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Wang ZH, Lin YW, Wei XB, Li F, Liao XL,
Yuan HQ, Huang DZ, Qin TH, Geng H and Wang SH: Predictive value of
prognostic nutritional index on COVID-19 severity. Front Nutr.
7(582736)2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Nalbant A, Demirci T, Kaya T, Aydın A,
Altındiş M and Güçlü E: Can prognostic nutritional index and
systemic immune-inflammatory index predict disease severity in
COVID-19? Int J Clin Pract. 75(e14544)2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Rashedi S, Keykhaei M, Pazoki M, Ashraf H,
Najafi A, Kafan S, Peirovi N, Najmeddin F, Jazayeri SA, Kashani M,
et al: Clinical significance of prognostic nutrition index in
hospitalized patients with COVID-19: Results from single-center
experience with systematic review and meta-analysis. Nutr Clin
Pract. 36:970–983. 2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wei W, Wu X, Jin C, Mu T, Gu G, Min M, Mu
S and Han Y: Predictive significance of the prognostic nutritional
index (PNI) in patients with severe COVID-19. J Immunol Res.
2021(9917302)2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Çınar T, Hayıroğlu Mİ, Çiçek V, Kılıç Ş,
Asal S, Yavuz S, Selçuk M, Yalçınkaya E, Keser N and Orhan AL: Is
prognostic nutritional index a predictive marker for estimating
all-cause in-hospital mortality in COVID-19 patients with
cardiovascular risk factors? Heart Lung. 50:307–312.
2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Bazargan M, Elahi R and Esmaeilzadeh A:
OMICRON: Virology, immunopathogenesis, and laboratory diagnosis. J
Gene Med. 24(e3435)2022.PubMed/NCBI View Article : Google Scholar
|
